Drug Executive Collapses During Oval Office Press Conference
During a Thursday press conference in the Oval Office, a drug executive suddenly collapsed while President Donald Trump was announcing a deal to reduce obesity drug prices.
Incident Details
The event was focused on a new agreement involving Eli Lilly and Novo Nordisk to expand coverage and lower prices for obesity treatments Zepbound and Wegovy. At one point, Eli Lilly's CEO David Ricks, who was speaking, noticed the executive’s condition and asked,
“Are you okay? Gordon, are you okay?”
Response and Aftermath
The man who fainted was identified as Gordon Findlay, Novo Nordisk’s global brand director. Dr. Mehmet Oz quickly assisted as Findlay collapsed to his knees. The press was then asked to leave the room as the situation was managed. Also present was the Health and Human Services Secretary.
Press Conference Resumed
About 30 minutes later, the press conference restarted, and President Trump provided an update on Findlay's condition.
President Trump said the executive was recovering after the incident during the announcement on lowering drug prices.
Author's summary: A sudden collapse of a drug executive during a high-profile Oval Office event led to an urgent pause, with medical help rendered and the press conference later resumed by President Trump.
Would you like the summary to be more formal or conversational?